Eva Albertini,Elisabeth Mayr,Andrea Taferner,Haymo Pircher,Pidder Jansen-Duerr,Susanne von Grafenstein,Christian Kramer,Klaus R. Liedl,Thomas Diener,Christina Metzger
申请号：
US15523507
公开号：
US20170312343A1
申请日:
2015.10.30
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides FAHD1 for use in a method for the treatment or prevention of aberrations of the energy metabolism of the nervous system, pancreas, kidney, liver, muscles or adipose tissue. Further, a method of decarboxylating an organic compound is provided, which uses FAHD1 to decarboxylate the organic compound. Additionally, a method and a kit for identifying inhibitors of FAHD1 are provided.
